Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 3 studies | 24% ± 4% | |
epithelial cell | 3 studies | 23% ± 10% | |
astrocyte | 3 studies | 19% ± 1% | |
glutamatergic neuron | 3 studies | 38% ± 20% | |
oligodendrocyte precursor cell | 3 studies | 18% ± 1% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 3 studies | 31% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
ovary | 100% | 1347.68 | 180 / 180 | 100% | 22.39 | 428 / 430 |
breast | 100% | 1194.72 | 459 / 459 | 99% | 11.61 | 1112 / 1118 |
bladder | 100% | 1031.14 | 21 / 21 | 99% | 11.37 | 501 / 504 |
intestine | 100% | 1064.09 | 966 / 966 | 99% | 11.70 | 523 / 527 |
uterus | 100% | 1436.06 | 170 / 170 | 99% | 11.67 | 455 / 459 |
stomach | 100% | 894.86 | 358 / 359 | 99% | 12.60 | 283 / 286 |
prostate | 100% | 1168.91 | 244 / 245 | 99% | 11.63 | 497 / 502 |
esophagus | 100% | 976.85 | 1444 / 1445 | 98% | 14.25 | 180 / 183 |
lung | 99% | 972.83 | 575 / 578 | 99% | 10.17 | 1141 / 1155 |
thymus | 100% | 1460.26 | 653 / 653 | 98% | 9.19 | 593 / 605 |
pancreas | 99% | 700.97 | 325 / 328 | 99% | 9.44 | 176 / 178 |
kidney | 100% | 1123.72 | 89 / 89 | 98% | 12.11 | 882 / 901 |
skin | 100% | 1301.17 | 1808 / 1809 | 97% | 8.45 | 460 / 472 |
brain | 96% | 622.21 | 2548 / 2642 | 98% | 10.18 | 692 / 705 |
adrenal gland | 100% | 1082.90 | 258 / 258 | 92% | 6.05 | 212 / 230 |
liver | 99% | 652.37 | 224 / 226 | 93% | 6.32 | 376 / 406 |
spleen | 100% | 1318.37 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 10.97 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 8.75 | 1 / 1 |
adipose | 100% | 953.97 | 1202 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 1042.00 | 1332 / 1335 | 0% | 0 | 0 / 0 |
heart | 96% | 473.77 | 829 / 861 | 0% | 0 | 0 / 0 |
muscle | 95% | 400.35 | 763 / 803 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 89% | 5.13 | 71 / 80 |
lymph node | 0% | 0 | 0 / 0 | 86% | 7.98 | 25 / 29 |
peripheral blood | 76% | 522.69 | 710 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0019509 | Biological process | L-methionine salvage from methylthioadenosine |
GO_0019284 | Biological process | L-methionine salvage from S-adenosylmethionine |
GO_0042995 | Cellular component | cell projection |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005829 | Cellular component | cytosol |
GO_0001650 | Cellular component | fibrillar center |
GO_0046523 | Molecular function | S-methyl-5-thioribose-1-phosphate isomerase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0005515 | Molecular function | protein binding |
Gene name | MRI1 |
Protein name | Methylthioribose-1-phosphate isomerase (M1Pi) (MTR-1-P isomerase) (EC 5.3.1.23) (Mediator of RhoA-dependent invasion) (S-methyl-5-thioribose-1-phosphate isomerase) (Translation initiation factor eIF-2B subunit alpha/beta/delta-like protein) |
Synonyms | UNQ6390/PRO21135 MRDI |
Description | FUNCTION: Catalyzes the interconversion of methylthioribose-1-phosphate (MTR-1-P) into methylthioribulose-1-phosphate (MTRu-1-P). Independently from catalytic activity, promotes cell invasion in response to constitutive RhoA activation by promoting FAK tyrosine phosphorylation and stress fiber turnover. . |
Accessions | Q9BV20 ENST00000319545.12 [Q9BV20-2] ENST00000040663.8 [Q9BV20-1] |